Euclidean Capital LLC
- SEC CIK
- 0001825034
- Latest filing
- Aug 14, 2026
Holdings in Q4 2022
Holdings as of Dec 31, 2022, filed Feb 14, 2023. Long positions only; changes compare share counts with Q3 2022.
- Positions
- 11
- +1 vs. Q3 2022
- Portfolio value
- $106.9M
- −$832.9K (−0.8%) vs. Q3 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| iShares MSCI India ETF46429B598 | ETF | 577,144 | $24.1M | 22.5% | +577,144 | New | – |
| MEHCQChrome Holding Co. | CLASS A COM | 10,243,122 | $22.1M | 20.7% | 00.0% | Unchanged | History |
| PMVPPMV Pharmaceuticals, Inc. | COM | 2,336,909 | $20.3M | 19.0% | 00.0% | Unchanged | History |
| ALECAlector, Inc. | COM | 980,894 | $9.05M | 8.5% | 00.0% | Unchanged | History |
| RAPTRAPT Therapeutics, Inc. | COM | 432,900 | $8.57M | 8.0% | 00.0% | Unchanged | History |
| FHTXFoghorn Therapeutics Inc. | COM | 1,261,261 | $8.05M | 7.5% | 00.0% | Unchanged | History |
| ORICOric Pharmaceuticals, Inc. | COM | 747,550 | $4.40M | 4.1% | 00.0% | Unchanged | History |
| FFBCFirst Financial Bancorp | COM | 173,576 | $4.21M | 3.9% | 00.0% | Unchanged | History |
| NGMNGM Biopharmaceuticals Inc | COM | 746,674 | $3.75M | 3.5% | 00.0% | Unchanged | History |
| TNYATenaya Therapeutics, Inc. | COM | 915,705 | $1.84M | 1.7% | 00.0% | Unchanged | History |
| SRZNSurrozen, Inc. | COM | 802,963 | $467.2K | 0.4% | 00.0% | Unchanged | History |